Literature DB >> 1544889

Brefeldin A-induced increase of sphingomyelin synthesis. Assay for the action of the antibiotic in mammalian cells.

A Brüning1, A Karrenbauer, E Schnabel, F T Wieland.   

Abstract

Brefeldin A leads to an increase of sphingomyelin in Chinese hamster ovary cells. The antibiotic is known to cause a dramatic morphological change of the endomembrane system in various mammalian cells resulting in a redistribution of Golgi resident proteins to the endoplasmic reticulum (Lippincott-Schwartz, J., Donaldson, J. G., Schweizer, A., Berger, E. G., Hauri, H. P., Yuan, L. C., and Klausner, R. D. (1990) Cell 60, 821-836). A strict correlation was found between the brefeldin A-induced increase of sphingomyelin and the biochemical criteria that apply for this morphological change. From our data we conclude that the increase in sphingomyelin caused by brefeldin A reflects translocation of the enzyme sphingomyelin synthase from the Golgi apparatus to the endoplasmic reticulum. Using a radioactively labeled truncated ceramide this increase in sphingomyelin synthesis is easily detectable, and thus this method can serve as a convenient biochemical assay for the action of brefeldin A in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1544889

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  7-Dehydrobrefeldin A, a naturally occurring brefeldin A derivative, inhibits secretion and causes a cis-to-trans breakdown of Golgi stacks in plant cells.

Authors:  A Driouich; A Jauneau; L A Staehelin
Journal:  Plant Physiol       Date:  1997-02       Impact factor: 8.340

2.  Use of photoactivatable sphingolipid analogues to monitor lipid transport in mammalian cells.

Authors:  M M Zegers; J W Kok; D Hoekstra
Journal:  Biochem J       Date:  1997-12-01       Impact factor: 3.857

3.  Limonoid compounds inhibit sphingomyelin biosynthesis by preventing CERT protein-dependent extraction of ceramides from the endoplasmic reticulum.

Authors:  Françoise Hullin-Matsuda; Nario Tomishige; Shota Sakai; Reiko Ishitsuka; Kumiko Ishii; Asami Makino; Peter Greimel; Mitsuhiro Abe; Elad L Laviad; Michel Lagarde; Hubert Vidal; Tamio Saito; Hiroyuki Osada; Kentaro Hanada; Anthony H Futerman; Toshihide Kobayashi
Journal:  J Biol Chem       Date:  2012-05-17       Impact factor: 5.157

4.  Plasmodium falciparum-infected erythrocytes utilize a synthetic truncated ceramide precursor for synthesis and secretion of truncated sphingomyelin.

Authors:  I Ansorge; D Jeckel; F Wieland; K Lingelbach
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

5.  Acute perturbations in Golgi organization impact de novo sphingomyelin synthesis.

Authors:  Suchismita Chandran; Carolyn E Machamer
Journal:  Traffic       Date:  2008-08-09       Impact factor: 6.215

6.  Transport of phosphatidylserine via MDR1 (multidrug resistance 1)P-glycoprotein in a human gastric carcinoma cell line.

Authors:  Antje Pohl; Hermann Lage; Peter Müller; Thomas Pomorski; Andreas Herrmann
Journal:  Biochem J       Date:  2002-07-01       Impact factor: 3.857

7.  The long-chain sphingoid base of sphingolipids is acylated at the cytosolic surface of the endoplasmic reticulum in rat liver.

Authors:  K Hirschberg; J Rodger; A H Futerman
Journal:  Biochem J       Date:  1993-03-15       Impact factor: 3.857

8.  Transport of newly synthesized glucosylceramide to the plasma membrane by a non-Golgi pathway.

Authors:  D E Warnock; M S Lutz; W A Blackburn; W W Young; J U Baenziger
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

9.  Probing de novo sphingolipid metabolism in mammalian cells utilizing mass spectrometry.

Authors:  Justin M Snider; Ashley J Snider; Lina M Obeid; Chiara Luberto; Yusuf A Hannun
Journal:  J Lipid Res       Date:  2018-04-02       Impact factor: 5.922

10.  Effects of brefeldin A on sphingomyelin transport and lipid synthesis in BHK21 cells.

Authors:  K J Kallen; P Quinn; D Allan
Journal:  Biochem J       Date:  1993-01-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.